Mohammad Ali Sabbaghi

Cited by

	All	Since 2019
Citations	205	167
h-index	7	7
i10-index	6	6

201420152016201720182019202020212022202320241 6 5 3 20 22 42 25 28 38 12

Public access

View all

2 articles

4 articles

available

not available

Based on funding mandates

Co-authors

Federico RojoFundacion Jimenez DiazVerified email at fjd.es
Gil-Gomez Gresearcher (academic) IMIM (Institut Hoepital del Mar d'Investigacions Mèdiques), BarcelonaVerified email at upf.edu
Muntasell AuraIMIM (Hospital del Mar Medical Research Institute)Verified email at imim.es
Alireza HaghparastSenior ScientistVerified email at um.ac.ir
Abel Gonzalez-PerezInstitut de Recerca Biomedica BarcelonaVerified email at irbbarcelona.org
eBiology: A Life Sciences JournaliMaQPress
Hesam DehghaniFull Professor at Ferdowsi University of MashhadVerified email at um.ac.ir
Eloy EspinProfessor of Universitat Autonoma de BarcelonaVerified email at vhebron.net
Mohammad Hasan SheikhhaProfessor of Medical Genetics, Shahid Sadoughi University of Medical SciencesVerified email at ssu.ac.ir
J. Alejandro Pérez FidalgoHospital Clinico Universitario Valencia. Research Institute INCLIVA. University ValenciaVerified email at uv.es
Samaneh ShojaeiSchool of Advanced Technologies in Medicine, Shahid Beheshti University of Medical SciencesVerified email at sbmu.ac.ir
Morvarid SaeinasabThe University of ManchesterVerified email at manchester.ac.uk

Mohammad Ali Sabbaghi

PhD

Verified email at meduniwien.ac.at - Homepage

Breast Cancer Anti-Cancer Drug Resistance


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Defective cyclin B1 induction in trastuzumab-emtansine (T-DM1) acquired resistance in HER2-positive breast cancer MA Sabbaghi, G Gil-Gómez, C Guardia, S Servitja, O Arpí, ... Clinical Cancer Research 23 (22), 7006-7019, 2017	82	2017
Poly (ADP-ribose) polymerase inhibition enhances trastuzumab antitumour activity in HER2 overexpressing breast cancer J García-Parra, A Dalmases, B Morancho, O Arpí, S Menendez, ... European Journal of Cancer 50 (15), 2725-2734, 2014	32	2014
IL-17A concentration of seminal plasma and follicular fluid in infertile men and women with various clinical diagnoses MA Sabbaghi, R Aram, H Roustaei, M Fadavi Islam, M Daneshvar, ... Immunological investigations 43 (7), 617-626, 2014	30	2014
Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma F Rojo, A González-Pérez, J Furriol, MJ Nicolau, J Ferrer, O Burgués, ... British journal of cancer 115 (3), 322-331, 2016	28	2016
Preclinical and clinical characterization of fibroblast-derived neuregulin-1 on trastuzumab and pertuzumab activity in HER2-positive breast cancer C Guardia, G Bianchini, O Arpí-LLucià, S Menendez, D Casadevall, ... Clinical Cancer Research 27 (18), 5096-5108, 2021	13	2021
Targeted metabolomics in formalin-fixed paraffin-embedded tissue specimens: Liquid chromatography-tandem mass spectrometry determination of acidic metabolites in cancer research A Gomez-Gomez, MA Sabbaghi, N Haro, J Albanell, S Menéndez, ... Talanta 223, 121740, 2021	12	2021
mTOR inhibition and T-DM1 in HER2-positive breast cancer D Casadevall, A Hernández-Prat, S García-Alonso, O Arpí-Llucià, ... Molecular Cancer Research 20 (7), 1108-1121, 2022	8	2022

The system can't perform the operation now. Try again later.

Articles 1–7

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors